New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Implantable Cardioverter Defibrillator Market size is expected to be worth around USD 7.7 Billion by ...

Fast Company will host the Most Innovative Companies Summit and Gala for honorees on May 19 in New York City. The summit features a day of inspiring content, followed by a creative black-tie gala ...

Please provide your email address to receive an email when new articles are posted on . A novel adhesive-based wearable cardioverter defibrillator exceeded its safety and efficacy performance goals.

What is Implantable Cardioverter Defibrillator (ICD)? The electrical activity of the heart keeps the heart beating constantly at a regular rhythm. A disturbance in this rhythm is called an arrhythmia.

Outdoor ambient weather has been hypothesized to be responsible for the seasonal distribution of cardiac arrhythmias. Because people spend most of their time indoors, we hypothesized that ...

Few medical therapies pose the issue of how to avoid sudden cardiac death as starkly as does the implantable cardioverter defibrillator — a device that is implanted like a pacemaker, which has been ...

New York, March 31, 2021 (GLOBE NEWSWIRE) -- Key Companies Covered in the Wearable Cardioverter Defibrillator Market Research Report Are Koninklijke Philips N.V., Element Science, Inc., Kestra Medical ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Abbreviations: ACS, acute coronary syndrome; AF, atrial fibrillation; AH, arterial hypertension; CAF, chronic atrial fibrillation; CDRIE, cardiac device–related ...

Heart failure is a deadly disease. Every year, tens of thousands of patients die from this condition, many of them suddenly. Efforts aimed at reducing mortality centered initially on antagonizing the ...

The implantable cardioverter-defibrillator (ICD) is the only therapy proven to reduce the risk of sudden cardiac death for both primary and secondary prevention. A recent worldwide survey has shown a ...